Cargando…

Is nature truly healing itself? Spontaneous remissions in Paroxysmal Nocturnal Hemoglobinuria

Detalles Bibliográficos
Autores principales:	Gurnari, Carmelo, Pagliuca, Simona, Kewan, Tariq, Bahaj, Waled, Mori, Minako, Patel, Bhumika J., Visconte, Valeria, Maciejewski, Jaroslaw P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627504/ https://www.ncbi.nlm.nih.gov/pubmed/34839350 http://dx.doi.org/10.1038/s41408-021-00582-5

Ejemplares similares

Current Opinions on the Clinical Utility of Ravulizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria
por: Gurnari, Carmelo, et al.
Publicado: (2021)

New approaches to idiopathic neutropenia in the era of clonal hematopoiesis
por: Ogbue, Olisaemeka D., et al.
Publicado: (2023)

Comprehensive Transcriptomic Analysis of VISTA in Acute Myeloid Leukemia: Insights into Its Prognostic Value
por: Pagliuca, Simona, et al.
Publicado: (2022)

Paroxysmal Nocturnal Hemoglobinuria: Biology and Treatment
por: Bravo-Perez, Carlos, et al.
Publicado: (2023)

Spontaneous Remission in Paroxysmal Nocturnal Hemoglobinuria: An Extremely Rare Case
por: Mehtap, Özgür, et al.
Publicado: (2022)

Large Granular Lymphocytic Leukemia: From Immunopathogenesis to Treatment of Refractory Disease
por: Zawit, Misam, et al.
Publicado: (2021)

Spontaneous Remission in Paroxysmal Nocturnal Hemoglobinuria—Return to Health or Transition Into Malignancy?
por: Korkama, Eva-Stina, et al.
Publicado: (2018)

A multimodal analysis of genomic and RNA splicing features in myeloid malignancies
por: Durmaz, Arda, et al.
Publicado: (2023)

Danicopan: an oral complement factor D inhibitor for paroxysmal nocturnal hemoglobinuria
por: Risitano, Antonio M., et al.
Publicado: (2020)

Genomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets
por: Mori, Minako, et al.
Publicado: (2023)

Necrotizing Fasciitis in Paroxysmal Nocturnal Hemoglobinuria
por: Patir, Pusem, et al.
Publicado: (2015)

Evolutionary dynamics of paroxysmal nocturnal hemoglobinuria
por: Mon Père, Nathaniel, et al.
Publicado: (2018)

Renal Manifestations in Paroxysmal Nocturnal Hemoglobinuria
por: Ram, R., et al.
Publicado: (2017)

Insights Into the Emergence of Paroxysmal Nocturnal Hemoglobinuria
por: Colden, Melissa A., et al.
Publicado: (2022)

Management of paroxysmal nocturnal hemoglobinuria (PNH)
por: Luzzatto, Lucio
Publicado: (2022)

Early Mortality in Paroxysmal Nocturnal Hemoglobinuria
por: Sørensen, Anne Lykke, et al.
Publicado: (2023)

Pregnancy in Classical Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia–Paroxysmal Nocturnal Hemoglobinuria: A High-Risk Constellation
por: Alashkar, Ferras, et al.
Publicado: (2020)

C3 inhibition with pegcetacoplan in subjects with paroxysmal nocturnal hemoglobinuria treated with eculizumab
por: de Castro, Carlos, et al.
Publicado: (2020)

Hemoglobinuria Misidentified as Hematuria: Review of Discolored Urine and Paroxysmal Nocturnal Hemoglobinuria
por: Veerreddy, Prashant
Publicado: (2013)

A Case of Paroxysmal Cold Hemoglobinuria Possessing Moderate Paroxysmal Nocturnal Hemoglobinuria-Type Erythrocytes
por: Sugimoto, Takeshi, et al.
Publicado: (2021)

Phase 2 study of danicopan in patients with paroxysmal nocturnal hemoglobinuria with an inadequate response to eculizumab
por: Kulasekararaj, Austin G., et al.
Publicado: (2021)

The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab
por: Kelly, Richard, et al.
Publicado: (2009)

Moyamoya Syndrome Caused by Paroxysmal Nocturnal Hemoglobinuria
por: Cheng, Zhi-Juan, et al.
Publicado: (2018)

Paroxysmal Nocturnal Hemoglobinuria in the Differential Diagnosis of Thrombocytopenia
por: Gediz, Fusun, et al.
Publicado: (2017)

The Role of T Lymphocytes in the Pathogenesis of Paroxysmal Nocturnal Hemoglobinuria
por: Li, Chenyuan, et al.
Publicado: (2021)

Safety and efficacy of pegcetacoplan in paroxysmal nocturnal hemoglobinuria
por: Wong, Raymond S.M.
Publicado: (2022)

Novel Scheme for Defining the Clinical Implications of TP53 Mutations in Myeloid Neoplasia
por: Bahaj, Waled, et al.
Publicado: (2023)

Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia
por: Bahaj, Waled, et al.
Publicado: (2023)

Prolonged Remission of Cancer of Unknown Primary following Initiation of Eculizumab Therapy for Paroxysmal Nocturnal Hemoglobinuria
por: Lim, Ming Y., et al.
Publicado: (2019)

Comparison of High Sensitivity and Conventional Flow Cytometry for Diagnosing Overt Paroxysmal Nocturnal Hemoglobinuria and Detecting Minor Paroxysmal Nocturnal Hemoglobinuria Clones
por: Park, Sang Hyuk, et al.
Publicado: (2019)

Molecular patterns identify distinct subclasses of myeloid neoplasia
por: Kewan, Tariq, et al.
Publicado: (2023)

Deficiency of the homologous restriction factor in paroxysmal nocturnal hemoglobinuria
Publicado: (1987)

Recent advances in the pathogenesis and treatment of paroxysmal nocturnal hemoglobinuria
por: Luzzatto, Lucio
Publicado: (2016)

Autosplenectomy in a Patient with Paroxysmal Nocturnal Hemoglobinuria (PNH)
por: Burns, Ethan, et al.
Publicado: (2019)

Paroxysmal Nocturnal Hemoglobinuria: Diagnostic Challenges in Pediatric Patient
por: Krishnaprasadh, Dharshana, et al.
Publicado: (2019)

Diagnostic and Treatment Challenges of Paroxysmal Nocturnal Hemoglobinuria in Uganda
por: Lumori, Boniface Amanee Elias, et al.
Publicado: (2019)

Paroxysmal Nocturnal Hemoglobinuria: An Underestimated Cause of Pediatric Thromboembolism
por: Griesser, Christina, et al.
Publicado: (2020)

COVID‐19 infection presenting as paroxysmal nocturnal hemoglobinuria
por: Hines, Adam, et al.
Publicado: (2021)

The importance of terminal complement inhibition in paroxysmal nocturnal hemoglobinuria
por: Kulasekararaj, Austin G., et al.
Publicado: (2022)

Paroxysmal nocturnal hemoglobinuria: current treatments and unmet needs
por: Bektas, Meryem, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_velb9o3s74pvlu787crgm4c2c7